Abiopharma

Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in India

RadNet Expands to Southwest Florida with Acquisition of Radiology Regional

Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference

RadNet Names Four Leaders to Expanded Executive Roles

EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement

Ionis partner GSK announces positive topline results from B-Well 1 and B-Well 2 Phase 3 studies for bepirovirsen, a potential first-in-class medicine for chronic hepatitis B

Innate Pharma - Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025

Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia

Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025

Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering